ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,386.37
-0.45%
Dow Jones
39,806.77
0.00%
Gold vs US Dollar
2,427.265
0.03%
Brent Oil
82.325
-1.44%
Bitcoin
71,218.95
-0.32%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vaccitech PLC (VACC)

  7. Vaccitech PLC (VACC) News

Vaccitech (VACC)

Vaccitech PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VACC
DateTimeSourceHeadlineSymbolCompany
07/11/202314:20Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VACCVaccitech PLC
21/06/202312:30GlobeNewswire Inc.Arbutus Doses First Patient in Additional Treatment Arm of Phase 2a Triple Combination Clinical Trial that Includes a PD-1 Monoclonal AntibodyNASDAQ:VACCVaccitech PLC
14/11/202211:30TipRanksAnalysts Are Bullish on These Healthcare Stocks: RAPT Therapeutics (RAPT), Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
08/11/202211:30TipRanksAnalysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), Apellis Pharmaceuticals (APLS)NASDAQ:VACCVaccitech PLC
01/11/202210:25TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
31/10/202212:00GlobeNewswire Inc.Vaccitech Doses First Patients in HBV003, a Phase 2b Clinical Trial of VTP-300 immunotherapeutic candidate for Chronic HBV PatientsNASDAQ:VACCVaccitech PLC
03/10/202221:30GlobeNewswire Inc.Vaccitech to Present at Upcoming October Investor & Scientific ConferencesNASDAQ:VACCVaccitech PLC
07/09/202221:01GlobeNewswire Inc.Vaccitech to Present at Upcoming September Investors ConferencesNASDAQ:VACCVaccitech PLC
11/08/202211:25TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
09/08/202221:15GlobeNewswire Inc.Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:VACCVaccitech PLC
07/07/202221:15GlobeNewswire Inc.Vaccitech to Present at the William Blair Biotech Focus Conference 2022NASDAQ:VACCVaccitech PLC
23/06/202211:16TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
22/06/202211:00GlobeNewswire Inc.Vaccitech’s VTP-300 induced sustained reductions of surface antigen in patients with chronic hepatitis B both as a monotherapy and in combination with a single low dose of anti-PD-1NASDAQ:VACCVaccitech PLC
07/06/202213:05TipRanksAnalysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Ayala Pharmaceuticals (AYLA) and Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
06/06/202221:15GlobeNewswire Inc.Vaccitech to Present at the Jefferies Healthcare ConferenceNASDAQ:VACCVaccitech PLC
06/06/202212:30GlobeNewswire Inc.Arbutus and Vaccitech Dose First Patient in Phase 2a Clinical Trial Combining Therapies for the Treatment of Chronic Hepatitis B VirusNASDAQ:VACCVaccitech PLC
20/05/202216:30GlobeNewswire Inc.Vaccitech to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:VACCVaccitech PLC
17/05/202217:35TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:VACCVaccitech PLC
12/05/202217:10TipRanksAnalysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
11/05/202221:15GlobeNewswire Inc.Vaccitech Reports First Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:VACCVaccitech PLC
07/04/202211:25TipRanksVaccitech Plc (VACC) Gets a Buy Rating from H.C. WainwrightNASDAQ:VACCVaccitech PLC
06/04/202221:15GlobeNewswire Inc.Vaccitech Announces Notification of Milestone and Royalty Revenue Relating to Sales of Vaxzevria®NASDAQ:VACCVaccitech PLC
28/03/202211:25TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:VACCVaccitech PLC
25/03/202211:15GlobeNewswire Inc.Vaccitech Reports Full-Year 2021 Financial Results and Recent Corporate DevelopmentsNASDAQ:VACCVaccitech PLC
07/03/202213:00GlobeNewswire Inc.Vaccitech to Present at the Barclays Global Healthcare Conference 2022NASDAQ:VACCVaccitech PLC
19/01/202211:22TipRanksVaccitech Plc (VACC) Gets a Buy Rating from H.C. WainwrightNASDAQ:VACCVaccitech PLC
18/01/202208:00GlobeNewswire Inc.Cancer Research UK Dose First Patient in Phase I/IIa Trial of Lung Cancer Immunotherapy VaccineNASDAQ:VACCVaccitech PLC
13/01/202221:34GlobeNewswire Inc.Vaccitech to Host Virtual KOL Event on VTP-300, a Potential Functional Cure for Chronic Hepatitis B (CHB) Infection, and the Broader CHB Therapeutics LandscapeNASDAQ:VACCVaccitech PLC
15/12/202111:25TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Allogene Therapeutics (ALLO) and Vaccitech Plc (VACC)NASDAQ:VACCVaccitech PLC
13/12/202121:05GlobeNewswire Inc.Vaccitech acquires Avidea Technologies to expand product pipeline and strengthen scientific leadership in immunotherapies and vaccinesNASDAQ:VACCVaccitech PLC
 Showing the most relevant articles for your search:NASDAQ:VACC

Your Recent History

USOTC
WMTN
Westmountain Gold (PK)
COIN
USEGBP
UseChain Token
COIN
APESSETH
ApeHaven
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved